Invention Grant
US08404675B2 Benzazepine derivatives and methods of prophylaxis or treatment of 5HT2C receptor associated diseases
失效
苯扎西平衍生物和预防或治疗5HT2C受体相关疾病的方法
- Patent Title: Benzazepine derivatives and methods of prophylaxis or treatment of 5HT2C receptor associated diseases
- Patent Title (中): 苯扎西平衍生物和预防或治疗5HT2C受体相关疾病的方法
-
Application No.: US12729026Application Date: 2010-03-22
-
Publication No.: US08404675B2Publication Date: 2013-03-26
- Inventor: Brian Smith , Charles A. Gilson, III , Jeffrey Schultz , Jeffrey Smith
- Applicant: Brian Smith , Charles A. Gilson, III , Jeffrey Schultz , Jeffrey Smith
- Applicant Address: US CA San Diego
- Assignee: Arena Pharmaceuticals, Inc.
- Current Assignee: Arena Pharmaceuticals, Inc.
- Current Assignee Address: US CA San Diego
- Agency: Foley & Lardner LLP
- Main IPC: A61P25/00
- IPC: A61P25/00 ; A61K31/55 ; C07D223/16
Abstract:
The present invention relates to certain 1-substituted-2,3,4,5-tetrahydro-3-benzazepine derivatives of Formula (I), that are modulators of the 5HT2C receptor. Accordingly, compounds of the present invention are useful for the prophylaxis or treatment of 5HT2C receptor associated diseases, conditions or disorders, such as, obesity and related disorders.
Public/Granted literature
- US20100173894A1 BENZAZEPINE DERIVATIVES AND METHODS OF PROPHYLAXIS OR TREATMENT OF 5HT2C RECEPTOR ASSOCIATED DISEASES Public/Granted day:2010-07-08
Information query
